Rolf M.F. Berger

18.7k total citations · 3 hit papers
235 papers, 8.2k citations indexed

About

Rolf M.F. Berger is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Rolf M.F. Berger has authored 235 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Pulmonary and Respiratory Medicine, 119 papers in Cardiology and Cardiovascular Medicine and 112 papers in Epidemiology. Recurrent topics in Rolf M.F. Berger's work include Pulmonary Hypertension Research and Treatments (131 papers), Congenital Heart Disease Studies (108 papers) and Cardiovascular Issues in Pregnancy (48 papers). Rolf M.F. Berger is often cited by papers focused on Pulmonary Hypertension Research and Treatments (131 papers), Congenital Heart Disease Studies (108 papers) and Cardiovascular Issues in Pregnancy (48 papers). Rolf M.F. Berger collaborates with scholars based in Netherlands, United States and Switzerland. Rolf M.F. Berger's co-authors include Maurice Beghetti, Beatrijs Bartelds, Marcus T.R. Roofthooft, Hans L. Hillege, D. Dunbar Ivy, Elke S. Hoendermis, Damien Bonnet, Nazzareno Galiè, Michael G. Dickinson and Rosa Laura E. van Loon and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Rolf M.F. Berger

225 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bosentan Therapy in Patients With Eisenmenger Syndrome

2006 578 citations Nazzareno Galiè, Maurice Beghetti et al. Circulation profile →
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management

2018 352 citations Maurice Beghetti, Damien Bonnet et al. profile →
Pediatric Pulmonary Hypertension

2013 323 citations D. Dunbar Ivy, Rolf M.F. Berger et al. profile →

Peers

Countries citing papers authored by Rolf M.F. Berger

Since Specialization

Citations

This map shows the geographic impact of Rolf M.F. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf M.F. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf M.F. Berger more than expected).

Fields of papers citing papers by Rolf M.F. Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf M.F. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf M.F. Berger. The network helps show where Rolf M.F. Berger may publish in the future.

Co-authorship network of co-authors of Rolf M.F. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf M.F. Berger. A scholar is included among the top collaborators of Rolf M.F. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf M.F. Berger. Rolf M.F. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hemodynamic profiling of patients with a Fontan circulation using pulmonary pressure/flow relations during dobutamine stress and pulmonary vasodilation testing 2025 ·American Journal of Physiology-Heart and Circulatory Physiology ·(unknown), Elke S. Hoendermis, (unknown), Tjark Ebels, (unknown), Rolf M.F. Berger	0
2	Physical Activity Measured by Hip-Anchored Accelerometry in Pediatric Pulmonary Hypertension 2025 ·CHEST Journal ·Mark‐Jan Ploegstra, (unknown), (unknown), (unknown), S. Schwartz, Meindina G. Haarman, Matthieu Villeneuve, (unknown), Johannes M. Douwes, Rolf M.F. Berger	0
3	Predicting pulmonary hemodynamics in pediatric pulmonary arterial hypertension using cardiac magnetic resonance imaging and machine learning: an exploratory pilot study 2025 ·The International Journal of Cardiovascular Imaging ·Hung Chu, (unknown), (unknown), Johannes M. Douwes, Meindina G. Haarman, Tineke P. Willems, Rolf M.F. Berger, Mark‐Jan Ploegstra	0
4	Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review 2024 ·Journal of the American Heart Association ·(unknown), (unknown), Rolf M.F. Berger, Johannes M. Douwes	1
5	The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension 2024 ·Children ·(unknown), (unknown), (unknown), Mark‐Jan Ploegstra, Rolf M.F. Berger, Johannes M. Douwes	0
6	Decreased Muscle Strength in Children With Repaired Tetralogy of Fallot: Relation With Exercise Capacity 2023 ·Journal of the American Heart Association ·(unknown), H. van Duinen, Otto T. H. M. Lelieveld, (unknown), (unknown), Tineke P. Willems, (unknown), Natasha M. Maurits, Gideon J. du Marchie Sarvaas, Rolf M.F. Berger	3
7	Quantification of systemic-to-pulmonary collateral flow in univentricular physiology with 4D flow MRI 2022 ·Cardiology in the Young ·(unknown), Frandics P. Chan, Joost P. van Melle, Tjark Ebels, Jeffrey A. Feinstein, Rolf M.F. Berger, Tineke P. Willems	2
8	Cellular senescence impairs the reversibility of pulmonary arterial hypertension 2020 ·Science Translational Medicine ·Diederik E. van der Feen, Guido P. L. Bossers, Quint A. J. Hagdorn, Jan-Renier Moonen, Kondababu Kurakula, Robert Szulcek, James Chappell, Francesco Vallania, Michele Donato, Klaas Kok, Jaskaren Kohli, Arjen H. Petersen, (unknown), Marco Demaria, Marie‐José Goumans, Rudolf A. de Boer, Purvesh Khatri, Marlene Rabinovitch, Rolf M.F. Berger, Beatrijs Bartelds	85
9	Pulmonary artery size is associated with functional clinical status in the Fontan circulation 2019 ·Heart ·(unknown), (unknown), Sophie Meyer, (unknown), Tjark Ebels, Joost P. van Melle, Tineke P. Willems, Rolf M.F. Berger	14
10	Pulmonary vasodilator therapy as treatment for patients with a Fontan circulation: the Emperor’s new clothes? 2018 ·Pulmonary Circulation ·(unknown), Quint A. J. Hagdorn, Rolf M.F. Berger	4
11	A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE‐3 2017 ·British Journal of Clinical Pharmacology ·Rolf M.F. Berger, Martine Géhin, Maurice Beghetti, D. Dunbar Ivy, Andjela Kusic‐Pajic, Peter Cornelisse, Simon Grill, Damien Bonnet, (unknown)	20
12	Diminished liver microperfusion in Fontan patients: A biexponential DWI study 2017 ·PLoS ONE ·Hildebrand Dijkstra, Djoeke Wolff, Joost P. van Melle, Beatrijs Bartelds, Tineke P. Willems, Matthijs Oudkerk, Hans Hillege, Aad P. van den Berg, Tjark Ebels, Rolf M.F. Berger, Paul E. Sijens	11
13	Rapid Fire - Acute Heart Failure 2014 ·European Journal of Heart Failure ·Guido P. L. Bossers, Quint A. J. Hagdorn, Mark‐Jan Ploegstra, Marinus A.J. Borgdorff, Herman H.W. Silljé, Rolf M.F. Berger, Beatrijs Bartelds	20
14	Sildenafil Enhances Systolic Adaptation, but does not Prevent Diastolic Dysfunction, in the Pressure-Loaded Right Ventricle 2012 ·European Journal of Heart Failure ·Marinus A.J. Borgdorff, Beatrijs Bartelds, Michael G. Dickinson, (unknown), (unknown), André Zandvoort, Herman H.W. Silljé, Paul Steendijk, Maartje de Vroomen, Rolf M.F. Berger	56
15	Differential Responses of the Right Ventricle to Abnormal Loading Conditions in Mice: Pressure vs. Volume Load 2011 ·European Journal of Heart Failure ·Beatrijs Bartelds, Marinus A.J. Borgdorff, (unknown), Janny Takens, (unknown), Marcel G.J. Nederhoff, Nynke J. Elzenga, Wiek H. van Gilst, León J. De Windt, Rolf M.F. Berger	55
16	Predictors of long-term survival in pulmonary hypertension treated with bosentan 2011 ·The Journal of Heart and Lung Transplantation ·Paul Bresser, Jeroen C. Vis, Rolf M.F. Berger, Hubert W. Vliegen, Madelon C Vonk, Repke J. Snijder, Leon M. van den Toorn, Arie P.J. van Dijk, Karin A. Boomars, (unknown), Barbara J.M. Mulder	1
17	Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism 2009 ·Netherlands Heart Journal ·M. G. J. Duffels, Mart N. van der Plas, Sulaiman Surie, Michiel M. Winter, Berto J. Bouma, Maarten Groenink, Arie P.J. van Dijk, Elke S. Hoendermis, Rolf M.F. Berger, Paul Bresser, Barbara J.M. Mulder	8
18	Arrhythmias from Neonate to Adult, Part II 2008 ·Pacing and Clinical Electrophysiology ·Freek van den Heuvel, Isabelle C. Van Gelder, Peter P. Karpawich, Rolf M.F. Berger, Rudolphus Berger, (unknown), (unknown)	3
19	Bosentan Therapy in Patients With Eisenmenger Syndrome breakdown → 2006 ·Circulation ·Nazzareno Galiè, Maurice Beghetti, Michael Α. Gatzoulis, John Granton, Rolf M.F. Berger, Andrea Lauer, Eleonora Chiossi, Michael J. Landzberg	578
20	Aerodynamic design of the wing-fuselage junction for the high-performance sailplane Mu-31 2004 ·Rolf M.F. Berger, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact